Merozyne Therapeutics has been established to develop a treatment for MDC1A, a severe form of muscular dystrophy.
Merozyne Therapeutics has been established to develop a treatment for MDC1A, a severe form of muscular dystrophy.
SARomics Biostructures provides premium protein crystallization, protein crystallography and structure-based drug design outsourcing services.